| Dr Noland H Hagood Jr, MD | |
|
3004 Pine St, Arkadelphia, AR 71923-5325 | |
| (870) 246-2471 | |
| (870) 246-2476 |
| Full Name | Dr Noland H Hagood Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 3004 Pine St, Arkadelphia, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346259124 | NPI | - | NPPES |
| 114160001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | B90240 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-arkadelphia | Arkadelphia, AR | Hospital |
| St Vincent Hot Springs | Hot springs, AR | Hospital |
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health | 0648177949 | 71 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356481410 PECOS PAC ID: 7911802079 Enrollment ID: O20070607000040 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447568373 PECOS PAC ID: 7911802079 Enrollment ID: O20101116000177 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841598919 PECOS PAC ID: 0648177949 Enrollment ID: O20110617000161 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528478955 PECOS PAC ID: 0648177949 Enrollment ID: O20141111002454 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518356112 PECOS PAC ID: 0648177949 Enrollment ID: O20150413001105 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427630110 PECOS PAC ID: 0648177949 Enrollment ID: O20210504000413 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Noland H Hagood Jr, MD 3004 Pine St, Arkadelphia, AR 71923-5325 Ph: (870) 246-2471 | Dr Noland H Hagood Jr, MD 3004 Pine St, Arkadelphia, AR 71923-5325 Ph: (870) 246-2471 |
News Archive
Having a body mass index (BMI) in the overweight or obese range increases the risk of traumatic workplace injury, according to researchers at the Johns Hopkins Bloomberg School of Public Health's Center for Injury Research and Policy. Employer-sponsored weight loss and maintenance programs should be considered as part of a well-rounded workplace safety plan.
Patients might be at greater risk for developing bloodstream infections due to a common device used in hospitals around the country, according to a research team at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska.
The changing weather brings about many things: holiday excitement, a different wardrobe and—perhaps most annoyingly—cold and flu season.
4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.
Many physicians who tested their breast-examination skills on a new type of pressure-sensing breast model failed to detect masses deep in the breast because they were not pressing hard enough, a study has found.
› Verified 4 days ago
Dr. Mark T Jansen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3004 Pine St, Arkadelphia, AR 71923 Phone: 870-246-2471 Fax: 870-246-2476 | |
Dr. Sean D. Champion, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 Professional Park Dr, Arkadelphia, AR 71923 Phone: 870-403-1225 Fax: 870-497-1655 | |
Dr. Bryan D Mcdonnell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3004 Pine St, Arkadelphia, AR 71923 Phone: 870-246-2471 Fax: 870-246-2476 | |
Shelly C Bray, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 Professional Park Dr, Arkadelphia, AR 71923 Phone: 870-464-1515 Fax: 870-464-1514 |